PPARG and psoriasis: Since we proposed that the pathogenicity of downregulated PPARγ-downstream signalling is different in various types of cells, where this pathway was active, we compared the expression levels of PPARγ and the related genes in the CD3+ T cells obtained from the blood of psoriasis patients and lesional skin with similar parameters in CD3+ T cells of healthy volunteers and uninvolved skin, respectively.